TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth
Authors:
- Chen YanCYChen Yan
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 391 (1) , 111975
Abstract
No abstract availableKeywords
Funding Information
- Education Department of Jiangxi Province (GJJ160251)
- Education Department of Jiangxi Province (GJJ150142)
- National Natural Science Foundation of China (81760523)
- National Natural Science Foundation of China (81560396)
- National Natural Science Foundation of China (81960436)
- Jiangxi Provincial Department of Science and Technology (20192BCB23023)
- Jiangxi Provincial Department of Science and Technology (20171BAB215024)
- Jiangxi Provincial Department of Science and Technology (20181BBG70011)
This publication has 34 references indexed in Scilit:
- TAK1 regulates hepatic cell survival and carcinogenesisJournal of Gastroenterology, 2014
- Genome-Wide Screening Reveals That miR-195 Targets the TNF-α/NF-κB Pathway by Down-Regulating IΚB Kinase Alpha and TAB3 in Hepatocellular CarcinomaHepatology, 2013
- PIM1 kinase as a target for cancer therapyExpert Opinion on Investigational Drugs, 2012
- Direct molecular interactions between Beclin 1 and the canonical NFκB activation pathwayAutophagy, 2012
- Inhibition of autophagy by TAB2 and TAB3The EMBO Journal, 2011
- Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaOncogene, 2010
- Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2Nature Immunology, 2007
- TAB3, a new binding partner of the protein kinase TAK1Biochemical Journal, 2004
- Identification of a human NF-κB-activating protein, TAB3Proceedings of the National Academy of Sciences, 2004
- The Jak-STAT pathwayMolecular Immunology, 2000